979 related articles for article (PubMed ID: 9015187)
1. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
2. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
3. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
Beiqing L; Chen M; Whisler RL
J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
[TBL] [Abstract][Full Text] [Related]
4. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
Hughes CC; Pober JS
J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
[TBL] [Abstract][Full Text] [Related]
5. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
[TBL] [Abstract][Full Text] [Related]
8. The increase in the induction of IL-2 expression with caloric restriction is correlated to changes in the transcription factor NFAT.
Pahlavani MA; Harris MD; Richardson A
Cell Immunol; 1997 Aug; 180(1):10-9. PubMed ID: 9316634
[TBL] [Abstract][Full Text] [Related]
9. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
Hussain S; Kilbey A; Gillespie DA
Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
[TBL] [Abstract][Full Text] [Related]
10. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
11. Surface Ig receptor-induced nuclear AP-1-dependent gene expression in B lymphocytes.
Chiles TC; Rothstein TL
J Immunol; 1992 Aug; 149(3):825-31. PubMed ID: 1634770
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
Gruebele A; Zawaski K; Kaplan D; Novak RF
Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
[TBL] [Abstract][Full Text] [Related]
13. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T
Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
15. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
16. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
17. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
18. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
19. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
